TrialInternational journal of clinical oncology2022

Efficacy and safety of regorafenib dose-escalation therapy for Japanese patients with refractory metastatic colorectal cancer (RECC study).

Shun Ishiyama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.